The prevalence of antibodies to SARS-CoV-2 among blood donors in China

Author:

Chang LeORCID,Hou WanghengORCID,Zhao LeiORCID,Zhang Yali,Wang Yanbin,Wu Linfeng,Xu Tingting,Wang Lilin,Wang Juan,Ma Jian,Wang Lan,Zhao Junpeng,Xu Jing,Dong Juan,Yan Ying,Yang Ru,Li Yu,Guo Fei,Cheng Wenjuan,Su Yingying,Zeng Jinfeng,Han Wei,Cheng TongORCID,Zhang Jun,Yuan QuanORCID,Xia NingshaoORCID,Wang LunanORCID

Abstract

AbstractIn this study, we investigate the seroprevalence of SARS-CoV-2 antibodies among blood donors in the cities of Wuhan, Shenzhen, and Shijiazhuang in China. From January to April 2020, 38,144 healthy blood donors in the three cities were tested for total antibody against SARS-CoV-2 followed by pseudotype SARS-CoV-2 neutralization tests, IgG, and IgM antibody testing. Finally, a total of 398 donors were confirmed positive. The age- and sex-standardized SARS-CoV-2 seroprevalence among 18–60 year-old adults (18–65 year-old in Shenzhen) was 2.66% (95% CI: 2.24%–3.07%) in Wuhan, 0.033% (95% CI: 0.0029%–0.267%) in Shenzhen, and 0.0028% (95% CI: 0.0001%–0.158%) in Shijiazhuang, respectively. Female sex and older-age were identified to be independent risk factors for SARS-CoV-2 seropositivity among blood donors in Wuhan. As most of the population of China remained uninfected during the early wave of the COVID-19 pandemic, effective public health measures are still certainly required to block viral spread before a vaccine is widely available.

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Reference36 articles.

1. World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19—11 March 2020. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 (2020).

2. World Health Organization. Coronavirus disease (COVID-19) outbreak situation 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019 (2020).

3. Zhu, N., et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2001017 (2020).

4. Wu, F. et al. A new coronavirus associated with human respiratory disease in China. Nature 579, 265–269 (2020).

5. Wang, P., et al. The SARS-CoV-2 outbreak: diagnosis, infection prevention, and public perception. Clin Chem, https://doi.org/10.1093/clinchem/hvaa080 (2020).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3